Influential doctors aren't disclosing their drug company ties
- Written by Ray Moynihan, Senior Research Fellow, Bond University
The lack of transparency seems to be worse in certain disease areas, including diabetes and heart disease.rawpixel
In September, the New York Times revealed that one of the world’s top cancer specialists had quietly received millions of dollars from drug and other companies. And what’s more, he’d failed to disclose the payments in...
Read more: Influential doctors aren't disclosing their drug company ties